Randomized trial demonstrates HIF-1α's role in cardioprotection during oxidative stress in mice, suggesting novel therapeutic targets.
Adaptation to chronic hypoxia (CH) enhances myocardial tolerance to ischemia/reperfusion injury and is closely associated with stabilization of hypoxia-inducible factor-1 alpha (HIF-1α), a central transcription factor in hypoxic response. Given the central role of mitochondria in cardiac pathophysiology, we investigated the contribution of HIF-1α to cellular mechanisms underlying CH-induced cardioprotection, with a focus on proteomic remodeling, antioxidant defense, and regulation of the mitochondrial permeability transition pore (mPTP). Adult male wild-type and heterozygous Hif1a knockout mice were exposed to intermittent CH (7000 m, 8 h/day, 4 weeks) or kept under normoxia. Isolated perfused hearts treated with cyclosporine A, an inhibitor of mPTP opening, were subjected to global ischemia/reperfusion insult for infarct size determination. Quantitative label-free proteomics was conducted to assess HIF-1α-dependent changes. We evaluated oxidative stress, measured levels of proteins associated with antioxidant defense and mPTP regulation. In parallel, a proof-of-concept study was performed in transfected AC16 cardiomyocytes exposed to H 2 O 2 -induced oxidative stress. CH induced HIF-1α-dependent cardioprotection by limiting infarct size through regulation of mPTP opening. Moreover, CH attenuated oxidative stress and promoted the protective translocation of hexokinase-2 to mitochondria in an HIF-1α-dependent manner. Consistently, HIF-1α overexpression enhanced cardiomyocyte survival under oxidative stress, whereas HIF-1α inhibition by acriflavine reduced cell viability. These findings identify HIF-1α as a key mediator of CH-induced adaptive response and cardioprotection during I/R injury in the mouse heart, acting through mPTP regulation. Cardioprotective effect of adaptation to chronic hypoxia (CH) is associated with the stabilization of hypoxia-inducible factor-1α (HIF-1α), a key regulator of hypoxic response. We explored the link between HIF-1α signaling and mitochondrial function in the CH-induced beneficial effect with respect to mitochondrial permeability transition pore (mPTP). HIF-1α acted through remodeling of proteome, increased expression of antioxidant enzymes (e.g., SODC, GPX4), cytoprotective translocation of hexokinase-2 (HXK2) to mitochondria, and modulation of mPTP opening. Noteworthy is that HIF-1α improved the cardiomyocyte survival as it enhanced antioxidant defense resulting in reactive oxygen species (ROS) reduction and mPTP opening regulation.
No takes yet. Share an insight, caveat, or question.
Opletalová et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: